GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Transcenta Holding 6628.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

0.69

-9.87%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Transcenta Holding — daily HKEX:6628

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Transcenta Holding on TradingView ↗
Market value
HK$308.2m
Last close × shares
Volume
974.5k
Shares, 9 Nov 2026

About Transcenta Holding

Its shares trade on HKEX under the ticker 6628.HK. It has been listed since 29 September 2021. In the fiscal year to 31 December 2025, it reported revenue of CN¥7.2m and a net loss of CN¥198.5m. At that date it held total assets of CN¥925.2m and shareholders' equity of CN¥618.4m.

Transcenta Holding Ltd. is a clinical stage global biopharmaceutical company, which engages in discovery, research, development, and manufacturing of differentiated antibody therapies in therapeutic areas with high unmet medical needs. The company is headquartered in Suzhou, Anhui. The company went IPO on 2021-09-29. The firm's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The firm's all products are in the research and development (R&D) stage and have not been commercialized. The firm also provides contract developmentand manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.

Figures and description from our data supplier, not checked against the company's own report.

More about Transcenta Holding →

Latest on Transcenta Holding

Our reporting

We have not reported on Transcenta Holding yet.

Next results

31 Mar 2027

Due on 31 Mar 2027. Analysts expect earnings of -0.52 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Transcenta Holding's ticker?

Transcenta Holding trades as 6628.HK on HKEX, under ISIN KYG9005B1041.

What was Transcenta Holding's last closing price?

0.69 on 9 Nov 2026. The figure is in HKD and is never converted.

When does Transcenta Holding next report results?

Results are expected on 31 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.